May provide rapid relief from depressive symptoms for some individuals.
Have Questions? Call Us
Spravato® (esketamine) is an FDA-approved prescription nasal spray for adults with treatment-resistant depression (TRD) or Major Depressive Disorder with acute suicidal thoughts. It works differently from most oral antidepressants by targeting different neural pathways, offering a new option for those who have not found relief with other treatments.
Your safety is our highest priority. Spravato® is administered only in our certified clinic under the direct supervision of our healthcare professionals. Through a required safety program (REMS), we will professionally monitor you for at least two hours after treatment in a comfortable, private setting.
You will arrive at our clinic, where our team will get you settled comfortably and answer any questions before your treatment begins.
Under the guidance of our specialist, you will self-administer the nasal spray. You will then relax in your private room for a two-hour observation period.
After the monitoring period, our team will clear you for departure. You must have a pre-arranged ride home, as you cannot drive for the rest of the day.
For individuals who have struggled with persistent depression, Spravato® can offer a new opportunity for significant symptom improvement.
May provide rapid relief from depressive symptoms for some individuals.
A novel mechanism of action for those unresponsive to other antidepressants.
Administered in a controlled, safe environment to ensure your well-being.
Works alongside your oral antidepressant as part of a comprehensive treatment plan.